© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
February 11, 2012
The American Journal of Pharmacy Benefits
Saxagliptin, in combination with metformin, provides a durable, well-tolerated, and cost-effective treatment option for patients with type 2 diabetes mellitus, from a US payer perspective.
Total 1-year healthcare costs were not significantly reduced by 2 value-based insurance design programs for diabetic patients, although education appeared to improve quality of care.
February 10, 2012
Within the last 5 years changes to oncology private practice have led to these clinics aligning themselves with larger entities to maintain their practices.
The Pharmacy & Therapeutics Society has become the Specialty Healthcare Benefits Council (SHBC).
Drug shortages, whether caused by the manufacturers or the FDA, continue to escalate. The federal government has recently begun to address this concern.